Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs, Inc. submitted a Rule 144 notice reporting the sale/offer of 5,625 common shares tied to a restricted stock lapse dated 02/20/2026. The filing also discloses a prior sale of 2,500 common shares on 01/07/2026, producing a cumulative figure shown as 7,725 in the excerpt.
Blend Labs, Inc. director and officer Nima Ghamsari reported several equity transactions tied to restricted stock units on February 20, 2026. He acquired Class A common stock through derivative exercises/conversions in three tranches of 375,000, 125,000 and 114,229 shares at $0.00 per share as RSUs vested. A related footnote states each RSU converts into one share of Class A common. He also disposed of 201,733 shares of Class A common at $1.72 per share, with the shares withheld to cover tax obligations connected to the RSU vesting.
Ling Winnie reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. reported that its Head of Legal and People, Winnie Ling, received equity awards in the form of restricted stock units. She was granted 313,312 Restricted Stock Units, which will vest in equal quarterly installments over two years while she remains a service provider.
She also received 78,328 Performance-based Restricted Stock Units. These are eligible to vest in four equal tranches based on the company’s stock price performance through December 31, 2029, again conditioned on her continued service.
Ghamsari Nima reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. reported that Head of Blend and director Nima Ghamsari received equity awards in the form of restricted stock units. He was granted 913,832 Restricted Stock Units, each representing a contingent right to one share of BLND Class A common stock.
The RSUs vest in equal quarterly installments over two years, as long as he continues as a service provider. He also received 913,836 performance-based RSUs, which can vest in four equal tranches based on the company’s stock price performance through December 31, 2029, with continued service required.
Blend Labs, Inc. executive Brian Kneafsey, Head of Revenue, reported a planned sale of company stock. On January 15, 2026, he sold 25,000 shares of Blend Labs Class A common stock at an average price of $3.0568 per share, as disclosed in a Form 4 insider trading report. The transaction was executed under a Rule 10b5-1 trading plan that he adopted on March 14, 2025, which is designed to allow pre-scheduled trades. After this sale, he beneficially owns 649,824 shares of Class A common stock directly.
Blend Labs, Inc. insider Brian Kneafsey has filed a notice of proposed sale of 100,000 shares of common stock, to be sold through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 01/15/2026. The filing lists an aggregate market value for this planned sale of $305,680.00, compared with 256,119,535 shares outstanding of Blend Labs common stock. These 100,000 shares were acquired on 02/17/2020 through an exercise-and-hold transaction paid in cash. Over the past three months, Kneafsey has already sold three blocks of 25,000 Blend Labs shares each, generating gross proceeds of $83,509.00, $74,732.00, and $76,486.00.
Blend Labs, Inc. Principal Accounting Officer Oxana Tkach reported selling 2,500 shares of Class A common stock on January 7, 2026 at a price of $3.09 per share. This was a routine insider transaction reported on a Form 4.
After this sale, Tkach beneficially owned 77,017 shares of Blend Labs Class A common stock in direct ownership. The filing states that the sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on September 9, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Blend Labs has a planned sale of restricted shares under Rule 144. A shareholder filed notice to sell 2,500 shares of common stock through Charles Schwab on or about January 7, 2026 on the NYSE, with an indicated aggregate market value of $7,725.00.
The shares were originally acquired from Blend Labs, Inc. on May 20, 2025 through a restricted stock lapse as equity compensation. As of the filing, Blend Labs reported 256,119,535 shares of common stock outstanding, which is a baseline ownership figure rather than the amount being sold.
Blend Labs, Inc. reported that Matt Thomson has joined the company as Head of Revenue. The company disclosed this leadership change in connection with a press release dated January 6, 2026, which is included as an exhibit. The filing does not discuss financial results, but focuses on announcing this senior revenue-focused appointment.
Blend Labs, Inc. reported that its Head of Revenue, an officer of the company, sold 25,000 shares of Class A common stock on 12/15/2025 at a weighted average price of $3.0594 per share. The sale was made under a Rule 10b5-1 trading plan adopted on March 14, 2025, and the officer continues to directly own 674,824 shares after the transaction.